MarginsXMarginsX
Home › Markets › Health Care › VANI

Vivani Medical Inc. Common Stock (DE) (VANI)

VANI trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.02
+0.99% on the day
Market cap
$92.0M
Micro cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$26.6M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/0001753926-26-000548-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerVANI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2014
SEC CIK0001266806
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$26.6M
Operating income-$27.6M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$16.2M
Total assets$39.4M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
6.9 months
$14.6M cash at September 30, 2026
Share count, 1 year
+23.6%
2025-11-12 to 2026-11-12 · +76.8% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$26.6M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued."
10-Q 2026-11-12
Cash and burn$14.6M cash; operating cash flow -$6.3M a quarter.Report 2026-09-30
Shares outstanding90,203,356 (2026-11-12); 72,952,235 a year earlier; 51,025,060 three years earlier.Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-09-25
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBPM LLP, Walnut Creek, California, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $26.6M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$7.3M-$6.4M$14.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$6.4M-$6.0M$19.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$6.8M-$6.2M$19.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$6.6M-$6.7M$16.2MNo debt tags$010-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$6.5M-$6.4M$2.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
$0-$7.1M-$6.1M$6.8MNo debt tags$010-Q 2025-08-13
Q1 2025
2025-03-31
$0-$6.3M-$5.2M$13.0MNo debt tagsNeeds four quarters10-Q 2025-05-13
Q4 2024
2024-12-31
$0-$6.0M-$5.8M$18.4MNo debt tags$010-K 2025-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-25
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-16
Latest proxy
DEFA 14A
DEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 843 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.6%
1 month-14.4%
3 months-24.6%
Year to date-17.9%
1 year-25.5%
From 52-week high-36.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
OMOutset Medical Inc.$3.39-9.12%$64.0M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
ELMDElectromed Inc.$23.10-5.02%$188.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier